NCT00299832View on ClinicalTrials.gov

SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Japan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY